AbCelex Technologies Inc. (www.abcelex.com) is a privately-owned Canadian biotechnology company that has developed a proprietary camelid antibody platform and has engineered and tested an orally available class of antibodies in two infectious disease programs with proof of concept studies completed.
AbCelex has demonstrated successful expression of more than 50 diverse protein target antigens, generated more than 10 large functional libraries of immune and naïve origin. Our platform enables to rationally design and optimise discovery and therapeutic candidates with extended half-live, increased proteolytic stability, and tailored target binding affinity. Additionally, the ability to interchange antibody subunits, AbCelex can rapidly and efficiently create multi-specific and multivalent therapeutic agents suitable for a range of therapeutic applications. Company currently has one immuno-recruiting platform in early preclinical development.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 3403 American Drive, Mississauga,on L4v 1t4,canada
- Phone
- (647) 494-8787
- in****@****lex.com
- Industry
- Biotechnology
- Website
- abcelex.com
- HQ
- Mississauga, ON
Abcelex Technologies Inc. Questions
Abcelex Technologies Inc.'s helpline number is (647) 494-8787
Abcelex Technologies Inc.'s website is abcelex.com
Abcelex Technologies Inc.'s LinkedIn profile is https://ca.linkedin.com/company/abcelex-technologies-inc-
Abcelex Technologies Inc. has
3 employees.
View email and phone details for 3
employees at Abcelex Technologies Inc..
Abcelex Technologies Inc.'s industry is
Biotechnology
Abcelex Technologies Inc.'s top competitors are
Beagle Scientific Inc.,
Deep Biologics,
Orpheus Medica,
Ranomics,
Virotek Biosciences Inc.,
Cedarlane,
Vaxcyte,
Linearx, Inc.,
Microbix,
Nurture Growth Bio Fertilizer Inc.
Abcelex Technologies Inc.'s support email address is info@abcelex.com
Abcelex Technologies Inc.'s categories are Biotechnology
Abcelex Technologies Inc.'s founding year is 2010
